Organization
Takeda Pharmaceutical Company Limited, Osaka, Japan
2 abstracts
3 posters
Abstract
Feasibility and utilization of electronic patient-reported outcome measures for lung cancer in routine clinical care.Org: Takeda Development Center Americas, Inc., Lexington, MA, USA, Takeda Pharmaceutical Company Limited, Osaka, Japan, Carevive Systems, Inc., Piedmont Research Strategies,
Abstract
Integrated efficacy and safety of brigatinib in patients with ALK TKI-naive advanced ALK+ NSCLC in the ALTA-1L and J-ALTA studies.Org: University of Colorado Cancer Center, Sendai Kousei Hospital, Fujita Health University School of Medicine, Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, SongDang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea, Yonsei Cancer Center, Yonsei University Health System,